# AI-RBP-DrugDiscovery

### AI-Driven De Novo Molecular Design and Computational Validation Framework for RNA-Binding Protein-Targeted Therapeutics


![Python](https://img.shields.io/badge/Python-3.10+-blue)
![PyTorch](https://img.shields.io/badge/PyTorch-DeepLearning-red)
![RDKit](https://img.shields.io/badge/RDKit-Cheminformatics-green)
![GROMACS](https://img.shields.io/badge/GROMACS-MolecularDynamics-orange)
![License](https://img.shields.io/badge/License-MIT-yellow)

---

## Overview

AI-RBP-DrugDiscovery is an integrated computational platform designed to accelerate the discovery of novel therapeutics targeting RNA-Binding Proteins (RBPs). The framework combines state-of-the-art deep learning architectures, cheminformatics, molecular modeling, molecular dynamics simulations, and experimental validation strategies into a unified drug discovery workflow.

The pipeline begins with molecular representation learning from large-scale chemical datasets and progresses through de novo molecular generation, physicochemical property prediction, protein-ligand interaction analysis, molecular docking, molecular dynamics simulations, and experimental validation.

This repository aims to bridge artificial intelligence and translational medicine by providing an end-to-end framework for the discovery of next-generation therapeutics.

---

## Research Motivation

RNA-Binding Proteins (RBPs) play critical roles in:

* Gene expression regulation
* RNA processing
* Alternative splicing
* mRNA stability
* Cellular signaling pathways

Dysregulation of RBPs has been implicated in:

* Renal diseases
* Cancer
* Neurodegenerative disorders
* Cardiovascular diseases
* Metabolic syndromes

Traditional drug discovery approaches are often expensive and time-consuming. By integrating generative artificial intelligence with computational pharmacology, this project aims to significantly reduce the time and cost required to identify promising lead compounds.

---

## Workflow

### Step 1: Molecular Dataset Preparation

Input molecular datasets are collected from:

* ChEMBL
* PubChem
* DrugBank
* ZINC Database

Molecular representations include:

* SMILES
* Molecular fingerprints
* 2D descriptors
* 3D molecular structures

---

### Step 2: Data Augmentation

To improve model robustness, molecular augmentation strategies include:

* Randomized SMILES
* Molecular perturbations
* Self-supervised learning
* Contrastive learning

---

### Step 3: Molecular Representation Learning

The framework learns chemical language representations through:

#### Transformer Models

* Self-attention mechanisms
* Context-aware molecular embeddings
* Long-range dependency learning

#### LSTM Networks

* Sequential SMILES processing
* Molecular pattern recognition
* Generative molecular design

---

### Step 4: De Novo Molecular Generation

Novel compounds are generated using:

* Transformer-based generators
* Variational molecular encoders
* LSTM generative architectures
* Reinforcement learning optimization

Generated molecules are constrained based on:

* Drug-likeness
* Target affinity
* Synthetic accessibility
* Toxicity profiles

---

### Step 5: Molecular Property Prediction

The generated molecules are evaluated using predictive models for:

#### Physicochemical Properties

* Molecular Weight
* LogP
* Topological Polar Surface Area (TPSA)
* Hydrogen Bond Donors
* Hydrogen Bond Acceptors

#### Drug Discovery Properties

* Drug-likeness
* Solubility
* Permeability
* pKa
* Bioavailability

#### ADMET Properties

* Absorption
* Distribution
* Metabolism
* Excretion
* Toxicity

---

### Step 6: RNA-Binding Protein Target Analysis

Potential therapeutic targets are analyzed using:

* Protein sequence analysis
* Structural bioinformatics
* Binding pocket prediction
* Functional annotation

Target prioritization is performed using:

* Gene expression datasets
* Protein interaction networks
* Disease association databases

---

### Step 7: Molecular Docking

Protein-ligand interaction studies are conducted using:

* AutoDock Vina
* AutoDock-GPU
* Schrödinger Glide
* SwissDock

Docking analysis includes:

* Binding affinity
* Interaction fingerprints
* Hydrogen bonds
* Hydrophobic interactions
* Binding mode prediction

---

### Step 8: Molecular Dynamics Simulations

The stability of protein-ligand complexes is investigated through:

* GROMACS
* AMBER
* OpenMM

Simulation analyses include:

#### Structural Stability

* RMSD
* RMSF
* Radius of Gyration

#### Interaction Stability

* Hydrogen Bond Analysis
* Binding Free Energy
* MM-PBSA/MM-GBSA

#### Dynamic Behavior

* Principal Component Analysis
* Free Energy Landscape
* Conformational Sampling

---

### Step 9: Computational Validation

Generated compounds undergo comprehensive validation through:

* Binding energy calculations
* Molecular mechanics simulations
* Free energy estimations
* Interaction network analysis

Performance benchmarking is performed against:

* FDA-approved drugs
* Known inhibitors
* Reference compounds

---

### Step 10: Experimental Validation

Promising lead compounds proceed to experimental assessment.

#### Cell Line Studies

* Cell viability assays
* Cytotoxicity assays
* Dose-response analysis

#### Molecular Validation

* Western blotting
* qRT-PCR
* Immunofluorescence
* Protein expression profiling

#### Functional Validation

* Pathway analysis
* Target inhibition studies
* Mechanistic investigations

---

## Repository Structure

```text
AI-RBP-DrugDiscovery
│
├── data
│   ├── raw
│   ├── processed
│   └── smiles
│
├── notebooks
│   ├── 01_data_preparation.ipynb
│   ├── 02_representation_learning.ipynb
│   ├── 03_molecule_generation.ipynb
│   ├── 04_property_prediction.ipynb
│   ├── 05_docking.ipynb
│   ├── 06_md_simulation.ipynb
│   └── 07_validation.ipynb
│
├── src
│   ├── preprocessing
│   ├── transformer
│   ├── lstm
│   ├── molecular_generation
│   ├── docking
│   ├── simulations
│   ├── validation
│   └── visualization
│
├── models
│
├── results
│
├── docs
│
├── requirements.txt
│
└── README.md
```

---

## Technologies

### Artificial Intelligence

* PyTorch
* TensorFlow
* HuggingFace Transformers
* Scikit-Learn

### Cheminformatics

* RDKit
* DeepChem
* Mordred

### Molecular Modeling

* AutoDock Vina
* Schrödinger
* PyMOL
* ChimeraX

### Molecular Dynamics

* GROMACS
* AMBER
* OpenMM

### Bioinformatics

* Biopython
* Scanpy
* Seurat
* Cytoscape

---

## Applications

This framework can be adapted for:

* Cancer Drug Discovery
* Renal Disease Therapeutics
* Neurodegenerative Disorders
* Cardiovascular Diseases
* Precision Medicine
* RNA Therapeutics
* Multi-target Drug Discovery

---

## Future Directions

* Large Language Models for Molecular Design
* Graph Neural Networks for Drug Discovery
* Multimodal Drug Response Prediction
* Digital Twin-Based Therapeutics
* Foundation Models for Precision Medicine






---


